Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Complete Sequencing and Comparison of 12 Normal Karyotype M1 AML Genomes with 12 t(15;17) Positive M3-APL Genomes

Blood (2011) 118 (21): 404.

https://doi.org/10.1182/blood.V118.21.404.404

Published: 2011

Journal Articles

Complete characterization of the microRNAome in a patient with acute myeloid leukemia

Giridharan Ramsingh, Daniel C. Koboldt, Maria Trissal, Katherine B. Chiappinelli, Todd Wylie, Sunita Koul, Li-Wei Chang, Rakesh Nagarajan, Todd A. Fehniger, Paul Goodfellow, Vincent Magrini, Richard K. Wilson, Li Ding, Timothy J. Ley, Elaine R. Mardis, Daniel C. Link

Blood (2010) 116 (24): 5316–5326.

https://doi.org/10.1182/blood-2010-05-285395

Published: 2010

Includes: Supplemental data

Journal Articles

Resolution of a Clinical Dilemma with Whole Genome Sequencing, and Discovery of a New Mechanism for Generating PML-Rara: Insertional Fusion

John S. Welch, MD, PhD, Li Ding, PhD, Ken Chen, PhD, David E. Larson, PhD, Shashikant Kulkarni, PhD, Jacqueline E. Payton, MD, PhD, John Wallis, PhD, Joelle Veizer, BS, Michael D. McLellan, Tammi L. Vickery, BS, Jerry P. Reed, MS, Daniel C Koboldt, MS, Jeffery Klco, MD, John F. DiPersio, MD, PhD, Elaine R. Mardis, PhD, Timothy J Ley, MD, Richard K. Wilson, PhD, Peter Westervelt, MD, PhD

Blood (2010) 116 (21): 2755.

https://doi.org/10.1182/blood.V116.21.2755.2755

Published: 2010

Journal Articles

The NK Cell MicroRNA Transcriptome Defined by Next-Generation Sequencing Identifies IL-15-Signaled Alterations In Mature MiR-223 Expression, and MiR-223 as a Potential Regulator of Murine Granzyme B

Todd A Fehniger, MD, PhD, Todd Wylie, Elizabeth Germino, Jeffrey W Leong, Vincent J Magrini, PhD, Sunita Koul, Catherine R Keppel, Stephanie E Schneider, Daniel C Koboldt, MS, Ryan P Sullivan, Michael E Heinz, Seth D Crosby, MD, Rakesh Nagarajan, MD, PhD, Giridharan Ramsingh, MD, Daniel C Link, MD, Timothy J Ley, MD, Elaine R Mardis, PhD

Blood (2010) 116 (21): 104.

https://doi.org/10.1182/blood.V116.21.104.104

Published: 2010

Journal Articles

DNA Sequence of the Cancer Genome of a Patient with Therapy-Related Acute Myeloid Leukemia

Blood (2010) 116 (21): 580.

https://doi.org/10.1182/blood.V116.21.580.580

Published: 2010

Journal Articles

Mutations In the DNA Methyltransferase Gene DNMT3A Are Highly Recurrent In Patients with Intermediate Risk Acute Myeloid Leukemia, and Predict Poor Outcomes

Timothy J Ley, MD, Li Ding, PhD, Matthew J. Walter, MD, Michael D. McLellan, BS, Tamara Lamprecht, BS, David E. Larson, PhD, Cyriac Kandoth, PhD, Jacqueline E. Payton, MD, PhD, Jack Baty, BA, John S. Welch, MD, PhD, Christopher C. Harris, BS, Cheryl F. Lichti, PhD, R. Reid Townsend, MD, Robert S. Fulton, MS, David J. Dooling, PhD, Daniel C. Koboldt, MS, Heather Schmidt, BS, Qunyuan Zhang, PhD, John R. Osborne, BS, Ling Lin, MS, Michelle O'Laughlin, BS, Joshua F. McMichael, BS, Kim D. Delehaunty, BA, Sean D. McGrath, MS, Lucinda A. Fulton, MS, Vincent J. Magrini, PhD, Tammi L. Vickery, BS, Jasreet Hundal, MS, Lisa L. Cook, Joshua J. Conyers, Gary W. Swift, BS, Jerry P. Reed, MS, Patricia A. Alldredge, MS, Todd Wylie, BS, Jason Walker, BA, BS, Joelle Kalicki-Veizer, BS, Mark A. Watson, MD, PhD, Sharon Heath, William D. Shannon, PhD, Nobish Varghese, MS, Rakesh Nagarajan, MD, PhD, Peter Westervelt, MD, PhD, Michael H. Tomasson, MD, Daniel C. Link, MD, Timothy A. Graubert, MD, John F. DiPersio, MD, PhD, Elaine R. Mardis, PhD, Richard K. Wilson, PhD

Blood (2010) 116 (21): 99.

https://doi.org/10.1182/blood.V116.21.99.99

Published: 2010

Journal Articles

Detection of Novel Mutations In MDS/AML by Whole Genome Sequencing

Blood (2010) 116 (21): 299.

https://doi.org/10.1182/blood.V116.21.299.299

Published: 2010

NARROW

Complete Sequencing and Comparison of 12 Normal Karyotype M1 AML Genomes with 12 t(15;17) Positive M3-APL Genomes

Complete characterization of the microRNAome in a patient with acute myeloid leukemia

Resolution of a Clinical Dilemma with Whole Genome Sequencing, and Discovery of a New Mechanism for Generating PML-Rara: Insertional Fusion

The NK Cell MicroRNA Transcriptome Defined by Next-Generation Sequencing Identifies IL-15-Signaled Alterations In Mature MiR-223 Expression, and MiR-223 as a Potential Regulator of Murine Granzyme B

DNA Sequence of the Cancer Genome of a Patient with Therapy-Related Acute Myeloid Leukemia

Mutations In the DNA Methyltransferase Gene DNMT3A Are Highly Recurrent In Patients with Intermediate Risk Acute Myeloid Leukemia, and Predict Poor Outcomes

Detection of Novel Mutations In MDS/AML by Whole Genome Sequencing

Email alerts

ASH Publications

American Society of Hematology

Complete Sequencing and Comparison of 12 Normal Karyotype M1 AML Genomes with 12 t(15;17) Positive M3-APL Genomes

Complete characterization of the microRNAome in a patient with acute myeloid leukemia

Resolution of a Clinical Dilemma with Whole Genome Sequencing, and Discovery of a New Mechanism for Generating PML-Rara: Insertional Fusion

The NK Cell MicroRNA Transcriptome Defined by Next-Generation Sequencing Identifies IL-15-Signaled Alterations In Mature MiR-223 Expression, and MiR-223 as a Potential Regulator of Murine Granzyme B

DNA Sequence of the Cancer Genome of a Patient with Therapy-Related Acute Myeloid Leukemia

Mutations In the DNA Methyltransferase Gene DNMT3A Are Highly Recurrent In Patients with Intermediate Risk Acute Myeloid Leukemia, and Predict Poor Outcomes

Detection of Novel Mutations In MDS/AML by Whole Genome Sequencing

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only